Welcome to medications.com

Walking the line - Investors Chronicle

Vyvanse is Shire's replacement for its blockbuster attention deficit and hyperactivity disorder (ADHD) treatment Adderall XR which will run out of patent ...

http://www.investorschronicle.co.... | Posted: Wed Mar 05 03:40:57 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com